Sep 18, 2013, 02.39 PM | Source: CNBC-TV18
Manoj Murlidharan Vayalar of IIFL recommends selling Sun Pharmaceutical Industries with a target of Rs 520 and a stoploss at Rs 555.
Manoj Murlidharan (more)
Head- Derivatives, Religare Securities | Capital Expertise: F&O
At 14:12 hrs Sun Pharmaceutical Industries was quoting at Rs 544.55, up Rs 0.20, or 0.04 percent. It has touched an intraday high of Rs 550 and an intraday low of Rs 535.55.
The share touched its 52-week high Rs 583 and 52-week low Rs 344.73 on 16 September, 2013 and 15 November, 2012, respectively. Currently, it is trading 6.6 percent below its 52-week high and 57.96 percent above its 52-week low. Market capitalisation stands at Rs 112,785.23 crore.
Disclosure: We have discussed this with our clients but no personal holdings.
Sun Pharma has significant investment plans for it
Drug major Sun Pharmaceutical Industries today com
"The company on October 18 completed buyback of 75
Net Sales are expected to decrease by 10.1 percent
Sun Pharma will fund and support further developme